[Federal Register: August 7, 1998 (Volume 63, Number 152)]
[Notices]               
[Page 42427]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07au98-129]


[[Page 42427]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute of Allergy and Infectious Diseases; Notice of 
Meetings: National Advisory Allergy and Infectious Diseases Council; 
Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology 
Subcommittee; Microbiology and Infectious Diseases Subcommittee

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Advisory Allergy and Infectious Diseases Council, 
National Institute of Allergy and Infectious Diseases, and its 
subcommittees on September 24-25, 1998. Meetings of the Council, NAAIDC 
Allergy and Immunology Subcommittee, NAAIDC Microbiology and Infectious 
Diseases Subcommittee and the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be held at the National Institutes of Health, 
Bethesda, Maryland.
    The meeting of the full Council will be open to the public on 
September 24 and Building 31C, Conference Room 6, from 1 p.m. to 
approximately 3:45 p.m. for general discussion and program 
presentations.
    On September 25 the meetings of the NAAIDC Allergy and Immunology 
Subcommittee and NAAIDC Microbiology and Infectious Diseases 
Subcommittee will be open to the public from 8:30 a.m. until 
adjournment. The subcommittees will meet in Building 31C, conference 
rooms 8 and 6 respectively.
    The meeting of the NAAIDC Acquired Immunodeficiency Syndrome 
Subcommittee will be open to the public from 8:30 a.m. until 
adjournment, on September 25. The subcommittee will meet at the Natcher 
Building, Conference Room E1.
    In accordance with the provisions set forth in secs. 552b(c)(4) and 
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, the 
meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee, 
NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology 
and Infectious Diseases Subcommittee will be closed to the public for 
approximately four hours for review, evaluation, and discussion of 
individual grant applications. It is anticipated that this will occur 
from 8:30 a.m. until approximately 1 p.m. on September 24, in 
conference rooms 8, 7 and 6 respectively. The meeting of the full 
Council will be closed from 3:45 p.m. until recess on September 24 for 
the review, discussion, and evaluation of individual grant 
applications. These applications and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the applications, disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Ms. Claudia Goad, Committee Management Officer, National Institute 
Allergy and Infectious Diseases, Solar Building, Room 3C26, National 
Institutes of Health, Bethesda, Maryland 20892, 301-496-7601, will 
provide a summary of the meeting and a roster of committee members upon 
request. Individuals who plan to attend and need special assistance, 
such as sign language interpretations or other reasonable 
accommodations, should contact Ms. Goad in advance of the meeting.
    Dr. John McGowan, Director, Division of Extramural Activities, 
NIAD, NIH, Solar Building, Room 3C20, 6003 Executive Boulevard, 
Rockville, Maryland 20892, telephone 301-496-7291, will provide 
substantive program information.

(Catalog of Federal Domestic Assistance Program Nos. 93-855 
Immunology, Allergic and Immunologic Diseases Research, 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: July 31, 1998.
LaVerne Y. Stringfield,
Commitee Management Officer, NIH.
[FR Doc. 98-21237 Filed 8-6-98; 8:45 am]
BILLING CODE 4140-01-M